Literature DB >> 9209800

Antiendothelial cell antibodies (AECA) in patients with uveoretinitis.

C Edelsten1, D P D'Cruz.   

Abstract

AECAs have been found in 26% of patients with uveoretinitis in studies arising from three different laboratories, and their presence cannot simply be explained by coexisting extraocular disease. There is little correlation with ocular disease activity or other markers of systemic inflammation and vascular damage that can be found in this group of patients, but this lack of correlation has also been found in studies of more widespread inflammatory diseases. The changes found in the peripheral blood of patients with uveoretinitis are the result of a mixture of acute and chronic inflammation, reactions to coexisting tissue damage, as well as predisposing abnormalities of inflammation and hemostasis. Even patients with similar clinical appearances are unlikely to be pathologically homogeneous, and the reasons for the presence of AECA are likely to be various. Some patients may demonstrate a heightened antibody response to endothelium damaged by unknown mechanisms, whereas others may develop cytotoxic AECA as an integral part of the inflammatory process. The majority of serum samples with AECA demonstrated antibody-dependent cell-mediated cytotoxicity, but this potentially pathogenetic mechanism was only demonstrable in a minority of patients. It is unlikely that IgM AECA or complement-mediated cytotoxicity is a relevant mechanism of vascular damage in this group of patients. A subgroup of patients may be genetically predisposed to produce excess autoantibodies in response to tissue damage caused by a wide variety of insults. Sawyerr et al.(36) has suggested that increased serum levels of agalactosyl IgG may account for some of the AECA binding found in chronic inflammatory diseases: we have also found changes in agalactosyl IgG in patients with active isolated uveoretinitis (40), but levels did not correlate with levels of IgG AECA (unpublished results). Further longitudinal studies will be necessary on each subgroup of patients in order to determine the true clinical significance of these findings.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209800     DOI: 10.1007/bf02828276

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  34 in total

1.  Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis.

Authors:  Y Tanaka; N Tsukada; C S Koh; N Yanagisawa
Journal:  J Neuroimmunol       Date:  1987-12       Impact factor: 3.478

2.  Serum autoantibodies and uveitis.

Authors:  P Murray
Journal:  Br J Ophthalmol       Date:  1986-04       Impact factor: 4.638

3.  Systemic morbidity in patients with isolated idiopathic retinal vasculitis.

Authors:  H E Palmer; A G Zaman; C E Edelsten; M R Stanford; E M Graham
Journal:  Lancet       Date:  1995-08-19       Impact factor: 79.321

4.  Anticardiolipin antibodies in isolated retinal vasculitis.

Authors:  A G Zaman; M A Khamashta; E M Graham
Journal:  Am J Ophthalmol       Date:  1993-12-15       Impact factor: 5.258

5.  Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases.

Authors:  E Nylander Lundqvist; O Back; T K Nilsson; S Rantapaa-Dahlqvist
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

6.  Humoral and cellular immune responsiveness to human S-antigen in uveitis.

Authors:  G Doekes; R van der Gaag; A Rothova; Y van Kooyk; L Broersma; M J Zaal; G Dijkman; M E Fortuin; G S Baarsma; A Kijlstra
Journal:  Curr Eye Res       Date:  1987-07       Impact factor: 2.424

7.  Autoreactivity in patients with Behçet's disease.

Authors:  P V Taylor; M A Chamberlain; J S Scott
Journal:  Br J Rheumatol       Date:  1993-10

8.  Soluble intercellular adhesion molecule-1 (sICAM-1) as a marker of disease relapse in idiopathic uveoretinitis.

Authors:  A G Zaman; C Edelsten; M R Stanford; E M Graham; B A Ellis; H Direskeneli; D P D'Cruz; G R Hughes; D C Dumonde; G R Wallace
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

9.  Anti-endothelial cell antibodies in retinal vasculitis.

Authors:  C Edelsten; D D'Cruz; G R Hughes; E M Graham
Journal:  Curr Eye Res       Date:  1992       Impact factor: 2.424

10.  Thrombophilic factors in ischaemic and non-ischaemic idiopathic retinal vasculitis.

Authors:  H E Palmer; K M Jurd; B J Hunt; A G Zaman; M R Stanford; M D Sanders; E M Graham
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

View more
  1 in total

Review 1.  An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF).

Authors:  Tsuyoshi Shirai; Hiroshi Fujii; Masao Ono; Ryu Watanabe; Tomonori Ishii; Hideo Harigae
Journal:  Clin Dev Immunol       Date:  2013-01-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.